What is the price-to-earnings ratio of BioArctic?
The price-earnings ratio of BioArctic is currently 81.39.
BioArctic P/S 2025
BioArctic P/S
81.39
Ticker
BIOA B.ST
ISIN
SE0010323311
WKN
A2H5GS
As of Aug 16, 2025, BioArctic's P/S ratio stood at 81.39, a 18.83% change from the 68.49 P/S ratio recorded in the previous year.
The BioArctic P/S history
BioArctic Aktienanalyse
What does BioArctic do?
BioArctic AB is a Swedish biotechnology company founded in 2003. The company is based in Stockholm and focuses on the development of innovative therapeutics for nervous system diseases such as Alzheimer's, Parkinson's, and spinal cord injuries. The company uses its expertise in biological and chemical drug research to discover and develop new therapeutic possibilities, with a focus on Amyloid-Beta production. BioArctic's business strategy is based on partnerships with pharmaceutical and biotech companies worldwide, working closely with partners to develop therapies and products that meet the needs and expectations of patients and doctors. BioArctic conducts research in three different areas: Alzheimer's, Parkinson's, and spinal cord injuries. The company works with partners such as Nutricia, Eisai, Just Biotherapeutics, Abcam, Neuropharm, AbbVie, Q-Med, Uppsala University, and the Karolinska Institute to develop treatments for these conditions. BioArctic has already brought several promising products to market, including BAN2401 for Alzheimer's and SC0806 for spinal cord injuries. Overall, BioArctic is a leading company in biological and chemical drug research, with a focus on developing new therapies and products for the benefit of patients and doctors worldwide. BioArctic ist eines der beliebtesten Unternehmen auf Eulerpool.com.P/S Details
Decoding BioArctic's P/S Ratio
BioArctic's Price to Sales (P/S) Ratio is a crucial financial metric that measures the company's market valuation relative to its total sales revenue. It's calculated by dividing the company's market capitalization by its total sales over a specific period. A lower P/S ratio can indicate that the company is undervalued, while a higher ratio may suggest overvaluation.
Year-to-Year Comparison
Comparing BioArctic's P/S ratio yearly provides insights into how the market perceives the company’s value relative to its sales. An increasing ratio over time can indicate growing investor confidence, while a decreasing trend might reflect concerns about the company’s revenue generation capabilities or market conditions.
Impact on Investments
The P/S ratio is instrumental for investors evaluating BioArctic's stock. It offers insights into the company’s efficiency in generating sales and its market valuation. Investors use this ratio to compare similar companies within the same industry, aiding in selecting stocks that offer the best value for investment.
Interpreting P/S Ratio Fluctuations
Variations in BioArctic’s P/S ratio can result from changes in the stock price, sales revenue, or both. Understanding these fluctuations is crucial for investors to evaluate the company’s current valuation and future growth potential, aligning their investment strategies accordingly.
Frequently Asked Questions about BioArctic stock
How has the price-earnings ratio of BioArctic changed compared to last year?
The price-to-earnings ratio of BioArctic has increased by 18.83% increased compared to last year.
What consequences does a high price-earnings ratio have for investors?
A high price-to-earnings ratio indicates that the company's stock is relatively expensive and investors may potentially achieve a lower return.
What does a low price-earnings ratio mean?
A low price-earnings ratio means that the company's stock is relatively cheap and investors may potentially achieve a higher return.
Is the price-earnings ratio of BioArctic high compared to other companies?
Yes, the price-to-earnings ratio of BioArctic is high compared to other companies.
How does an increase in the price-earnings ratio of BioArctic affect the company?
An increase in the price-earnings ratio of BioArctic would lead to a higher market capitalization of the company, which in turn would lead to a higher valuation of the company.
How does a reduction in the price-to-earnings ratio of BioArctic affect the company?
A decrease in the price-earnings ratio of BioArctic would result in a lower market capitalization of the company, which in turn would lead to a lower valuation of the company.
What are some factors that influence the price-earnings ratio of BioArctic?
Some factors that influence the price-earnings ratio of BioArctic are the company's growth, financial position, industry development, and the overall economic situation.
How much dividend does BioArctic pay?
Over the past 12 months, BioArctic paid a dividend of 1.5 SEK . This corresponds to a dividend yield of about 0.63 %. For the coming 12 months, BioArctic is expected to pay a dividend of 8.85 SEK.
What is the dividend yield of BioArctic?
The current dividend yield of BioArctic is 0.63 %.
When does BioArctic pay dividends?
BioArctic pays a quarterly dividend. This is distributed in the months of .
How secure is the dividend of BioArctic?
BioArctic paid dividends every year for the past 5 years.
What is the dividend of BioArctic?
For the upcoming 12 months, dividends amounting to 8.85 SEK are expected. This corresponds to a dividend yield of 3.73 %.
In which sector is BioArctic located?
BioArctic is assigned to the 'Health' sector.
Wann musste ich die Aktien von BioArctic kaufen, um die vorherige Dividende zu erhalten?
To receive the latest dividend of BioArctic from 5/16/2019 amounting to 1.5 SEK, you needed to have the stock in your portfolio before the ex-date on 5/10/2019.
When did BioArctic pay the last dividend?
The last dividend was paid out on 5/16/2019.
What was the dividend of BioArctic in the year 2024?
In the year 2024, BioArctic distributed 0 SEK as dividends.
In which currency does BioArctic pay out the dividend?
The dividends of BioArctic are distributed in SEK.
Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.
Andere Kennzahlen von BioArctic
Our stock analysis for BioArctic Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of BioArctic Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.
